首页 > 最新文献

中国医学科学院学报最新文献

英文 中文
[Research Progress in the Role of the Ventral Tegmental Area-Medial Prefrontal Cortex Neural Circuit in the Regulation of Arousal]. [腹侧被盖区-内侧前额叶皮层神经环路在唤醒调节中的作用研究进展]。
Q4 Medicine Pub Date : 2024-06-01 DOI: 10.3881/j.issn.1000-503X.15693
Meng-Nan Hao, Xiao-Li Liang, Yi Zhang

There are mutual neural projections between the ventral tegmental area (VTA) and the medial prefrontal cortex (mPFC),which form a circuit.Recent studies have shown that this circuit is vital in regulating arousal from sleep and general anesthesia.This paper introduces the anatomical structures of VTA and mPFC and the roles of various neurons and projection pathways in the regulation of arousal,aiming to provide new ideas for further research on the mechanism of arousal from sleep and general anesthesia.

本文介绍了腹侧被盖区(VTA)和内侧前额叶皮层(mPFC)的解剖结构以及各种神经元和投射通路在唤醒调节中的作用,旨在为进一步研究睡眠和全身麻醉唤醒机制提供新思路。
{"title":"[Research Progress in the Role of the Ventral Tegmental Area-Medial Prefrontal Cortex Neural Circuit in the Regulation of Arousal].","authors":"Meng-Nan Hao, Xiao-Li Liang, Yi Zhang","doi":"10.3881/j.issn.1000-503X.15693","DOIUrl":"https://doi.org/10.3881/j.issn.1000-503X.15693","url":null,"abstract":"<p><p>There are mutual neural projections between the ventral tegmental area (VTA) and the medial prefrontal cortex (mPFC),which form a circuit.Recent studies have shown that this circuit is vital in regulating arousal from sleep and general anesthesia.This paper introduces the anatomical structures of VTA and mPFC and the roles of various neurons and projection pathways in the regulation of arousal,aiming to provide new ideas for further research on the mechanism of arousal from sleep and general anesthesia.</p>","PeriodicalId":6919,"journal":{"name":"中国医学科学院学报","volume":"46 3","pages":"402-408"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141475675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Expression Levels and Regulation of Selenoprotein Genes in Patients With Coronavirus Disease 2019]. [2019年冠状病毒疾病患者硒蛋白基因的表达水平和调控]。
Q4 Medicine Pub Date : 2024-06-01 DOI: 10.3881/j.issn.1000-503X.15834
Jing Li, Rong-Qiang Zhang, Ling-Zhi Zhang, Yan Qi, Jie Hao, Ao-Yue He, Xu Zhao, Xiu-Qin Li

Objective To investigate the expression levels of selenoprotein genes in the patients with coronavirus disease 2019 (COVID-19) and the possible regulatory mechanisms.Methods The dataset GSE177477 was obtained from the Gene Expression Omnibus,consisting of a symptomatic group (n=11),an asymptomatic group (n=18),and a healthy control group (n=18).The dataset was preprocessed to screen the differentially expressed genes (DEG) related to COVID-19,and gene ontology functional annotation and Kyoto encyclopedia of genes and genomes enrichment analysis were performed for the DEGs.The protein-protein interaction network of DEGs was established,and multivariate Logistic regression was employed to analyze the effects of selenoprotein genes on the presence/absence of symptoms in the patients with COVID-19.Results Compared with the healthy control,the symptomatic COVID-19 patients presented up-regulated expression of GPX1,GPX4,GPX6,DIO2,TXNRD1,SELENOF,SELENOK,SELENOS,SELENOT,and SELENOW and down-regulated expression of TXNRD2 and SELENON (all P<0.05).The asymptomatic patients showcased up-regulated expression of GPX2,SELENOI,SELENOO,SELENOS,SELENOT,and SELENOW and down-regulated expression of SELP (all P<0.05).The results of multivariate Logistic regression analysis showed that the abnormally high expression of GPX1 (OR=0.067,95%CI=0.005-0.904,P=0.042) and SELENON (OR=56.663,95%CI=3.114-856.999,P=0.006) was the risk factor for symptomatic COVID-19,and the abnormally high expression of SELP was a risk factor for asymptomatic COVID-19 (OR=15.000,95%CI=2.537-88.701,P=0.003).Conclusions Selenoprotein genes with differential expression are involved in the regulation of COVID-19 development.The findings provide a new reference for the prevention and treatment of COVID-19.

方法 从基因表达总库(Gene Expression Omnibus)中获得数据集 GSE177477,包括无症状组(n=11)、无症状组(n=18)和健康对照组(n=18)。对数据集进行预处理,筛选出与COVID-19相关的差异表达基因(DEG),并对DEG进行基因本体功能注释和京都基因和基因组百科全书富集分析,建立DEG的蛋白-蛋白相互作用网络,并采用多元Logistic回归分析硒蛋白基因对COVID-19患者症状有无的影响。结果 与健康对照组相比,有症状的 COVID-19 患者的 GPX1、GPX4、GPX6、DIO2、TXNRD1、SELENOF、SELENOK、SELENOS、SELENOT 和 SELENOW 表达上调,TXNRD2 和 SELENON 表达下调(所有 PPOR=0.067,95%CI=0.005-0.904,P=0.042)和SELENON(OR=56.663,95%CI=3.114-856.999,P=0.结论 具有差异表达的硒蛋白基因参与了COVID-19发病的调控,该研究结果为COVID-19的防治提供了新的参考。
{"title":"[Expression Levels and Regulation of Selenoprotein Genes in Patients With Coronavirus Disease 2019].","authors":"Jing Li, Rong-Qiang Zhang, Ling-Zhi Zhang, Yan Qi, Jie Hao, Ao-Yue He, Xu Zhao, Xiu-Qin Li","doi":"10.3881/j.issn.1000-503X.15834","DOIUrl":"https://doi.org/10.3881/j.issn.1000-503X.15834","url":null,"abstract":"<p><p>Objective To investigate the expression levels of selenoprotein genes in the patients with coronavirus disease 2019 (COVID-19) and the possible regulatory mechanisms.Methods The dataset GSE177477 was obtained from the Gene Expression Omnibus,consisting of a symptomatic group (<i>n</i>=11),an asymptomatic group (<i>n</i>=18),and a healthy control group (<i>n</i>=18).The dataset was preprocessed to screen the differentially expressed genes (DEG) related to COVID-19,and gene ontology functional annotation and Kyoto encyclopedia of genes and genomes enrichment analysis were performed for the DEGs.The protein-protein interaction network of DEGs was established,and multivariate Logistic regression was employed to analyze the effects of selenoprotein genes on the presence/absence of symptoms in the patients with COVID-19.Results Compared with the healthy control,the symptomatic COVID-19 patients presented up-regulated expression of GPX1,GPX4,GPX6,DIO2,TXNRD1,SELENOF,SELENOK,SELENOS,SELENOT,and SELENOW and down-regulated expression of TXNRD2 and SELENON (all <i>P</i><0.05).The asymptomatic patients showcased up-regulated expression of GPX2,SELENOI,SELENOO,SELENOS,SELENOT,and SELENOW and down-regulated expression of SELP (all <i>P</i><0.05).The results of multivariate Logistic regression analysis showed that the abnormally high expression of GPX1 (<i>OR</i>=0.067,95%<i>CI</i>=0.005-0.904,<i>P</i>=0.042) and SELENON (<i>OR</i>=56.663,95%<i>CI</i>=3.114-856.999,<i>P</i>=0.006) was the risk factor for symptomatic COVID-19,and the abnormally high expression of SELP was a risk factor for asymptomatic COVID-19 (<i>OR</i>=15.000,95%<i>CI</i>=2.537-88.701,<i>P</i>=0.003).Conclusions Selenoprotein genes with differential expression are involved in the regulation of COVID-19 development.The findings provide a new reference for the prevention and treatment of COVID-19.</p>","PeriodicalId":6919,"journal":{"name":"中国医学科学院学报","volume":"46 3","pages":"316-323"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141475666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Relationship Between Cerebrovascular Reactivity and Depression in Patients With End-Stage Renal Disease]. 终末期肾病患者脑血管反应性与抑郁之间的关系
Q4 Medicine Pub Date : 2024-06-01 DOI: 10.3881/j.issn.1000-503X.15891
Shu-Ying Li, Rui Chen, Wei-Ting Tang, Xiao-Jie Ma, Hua-Bin Cai, Yong You

Objective To investigate the relationship between cerebrovascular reactivity (CVR) and emotional disorders in the patients undergoing continuous hemodialysis for end-stage renal disease (ESRD).Methods The clinical data of the ESRD patients undergoing continuous hemodialysis were collected.Anxiety and depression of the patients were assessed by the Hamilton anxiety scale (HAMA) and Beck depression inventory,respectively.The cerebral hemodynamic changes during the breath holding test were monitored by transcranial Doppler sonography,and the breath-holding index (BHI) was calculated.The BHI≥0.69 and BHI<0.69 indicate normal CVR and abnormal CVR,respectively.Binary Logistic regression was employed to analyze the factors affecting the depressive state of ESRD patients.Results The group with abnormal CVR exhibited higher total cholesterol level (P=0.010),low density lipoprotein level (P=0.006),and incidence of depression (P=0.012) than the group with normal CVR.Compared with the non-depression group,the depression group displayed prolonged disease course (P=0.039),reduced body mass index (P=0.048),elevated HAMA score (P=0.001),increased incidence of anxiety (P<0.001),decreased BHI (P=0.015),and increased incidence of abnormal CVR (P=0.012).Binary Logistic regression analysis indicated anxiety as a contributing factor (OR=22.915,95%CI=2.653-197.956,P=0.004) and abnormal CVR as a risk factor (OR=0.074,95%CI=0.008-0.730,P=0.026) for depression.Conclusion Impaired CVR could pose a risk for depression in the patients with ESRD.

摘要] 目的 探讨终末期肾病(ESRD)连续血液透析患者脑血管反应性(CVR)与情绪障碍之间的关系。通过经颅多普勒超声监测憋气试验时的脑血流动力学变化,并计算憋气指数(BHI)。
{"title":"[Relationship Between Cerebrovascular Reactivity and Depression in Patients With End-Stage Renal Disease].","authors":"Shu-Ying Li, Rui Chen, Wei-Ting Tang, Xiao-Jie Ma, Hua-Bin Cai, Yong You","doi":"10.3881/j.issn.1000-503X.15891","DOIUrl":"10.3881/j.issn.1000-503X.15891","url":null,"abstract":"<p><p>Objective To investigate the relationship between cerebrovascular reactivity (CVR) and emotional disorders in the patients undergoing continuous hemodialysis for end-stage renal disease (ESRD).Methods The clinical data of the ESRD patients undergoing continuous hemodialysis were collected.Anxiety and depression of the patients were assessed by the Hamilton anxiety scale (HAMA) and Beck depression inventory,respectively.The cerebral hemodynamic changes during the breath holding test were monitored by transcranial Doppler sonography,and the breath-holding index (BHI) was calculated.The BHI≥0.69 and BHI<0.69 indicate normal CVR and abnormal CVR,respectively.Binary Logistic regression was employed to analyze the factors affecting the depressive state of ESRD patients.Results The group with abnormal CVR exhibited higher total cholesterol level (<i>P</i>=0.010),low density lipoprotein level (<i>P</i>=0.006),and incidence of depression (<i>P</i>=0.012) than the group with normal CVR.Compared with the non-depression group,the depression group displayed prolonged disease course (<i>P</i>=0.039),reduced body mass index (<i>P</i>=0.048),elevated HAMA score (<i>P</i>=0.001),increased incidence of anxiety (<i>P</i><0.001),decreased BHI (<i>P</i>=0.015),and increased incidence of abnormal CVR (<i>P</i>=0.012).Binary Logistic regression analysis indicated anxiety as a contributing factor (<i>OR</i>=22.915,95%<i>CI</i>=2.653-197.956,<i>P</i>=0.004) and abnormal CVR as a risk factor (<i>OR</i>=0.074,95%<i>CI</i>=0.008-0.730,<i>P</i>=0.026) for depression.Conclusion Impaired CVR could pose a risk for depression in the patients with ESRD.</p>","PeriodicalId":6919,"journal":{"name":"中国医学科学院学报","volume":" ","pages":"348-353"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141305100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Applicability of H2FPEF and HFA-PEFF Scores in Chinese Patients Suffering From Heart Failure With Preserved Ejection Fraction and Heart Failure With Preserved Ejection Fraction Complicated With Atrial Fibrillation]. [H2FPEF和HFA-PEFF评分在中国射血分数保留型心力衰竭和射血分数保留型心力衰竭并发心房颤动患者中的适用性】。]
Q4 Medicine Pub Date : 2024-04-01 DOI: 10.3881/j.issn.1000-503X.15826
Xiao-Yan Jia, Li-Xiang Liu, Dong-Wei Wang, Xi-Wen Ma, Yong-Ming Liu

Objective To analyze the diagnostic values of H2FPEF and HFA-PEFF scores for heart failure with preserved ejection fraction (HFpEF) and HFpEF complicated with atrial fibrillation (HFpEF-AF) in Chinese patients and explore the related factors. Methods A cross-sectional study was conducted.A total of 835 consecutive HFpEF patients treated in the Department of Geriatric Cardiology,the First Hospital of Lanzhou University from 2009 to 2020 were selected and assigned to a HFpEF-AF group (n=267) and a HFpEF group (n=568) according to the presence of AF or not.HFA-PEFF and H2FPEF scores were used for retrospective diagnosis and the diagnostic consistency of the two scores was assessed.One hundred and thirty-six healthy volunteers with age and sex matching the patients during the same period were selected as healthy controls.The receiver operating characteristic (ROC) curves were established for H2FPEF and HFA-PEFF scores in diagnosing HFpEF-AF and HFpEF,on the basis of which the diagnostic performance of the two scores was evaluated. Results There was no difference in the HFA-PEFF score between the two groups (P=0.070).However,the HFpEF-AF group had higher mean H2FPEF score and higher proportion of patients with the score no less than 6 than the HFpEF group (P<0.001).According to the ROC curves,HFA-PEFF and H2FPEF scores demonstrated high performance in diagnosing all HFpEF patients,with the area under the curve (AUC) of 0.892 and 0.922 and the optimal cut-offs of 4 and 4,respectively.The HFA-PEFF score showed similar performance in diagnosing HFpEF and HFpEF-AF,with the AUC of 0.899 and 0.911,respectively.The H2FPEF score had higher performance in diagnosing HFpEF-AF (AUC of approximately 1.000) and low performance in diagnosing HFpEF (AUC of 0.885). Conclusions The HFA-PEFF score is applicable in the diagnosis of both HFpEF and HFpEF-AF.The H2FPEF score may underestimate HFpEF in Chinese patients,and its applicability in the Chinese patients with HFpEF alone remains to be investigated.

目的 分析H2FPEF和HFA-PEFF评分对中国射血分数保留型心力衰竭(HFpEF)和合并房颤的HFpEF(HFpEF-AF)的诊断价值,并探讨相关因素。方法 选取2009-2020年兰州大学第一医院老年心内科连续收治的835例HFpEF患者,根据有无房颤分为HFpEF-AF组(n=267)和HFpEF组(n=568),采用HFA-PEFF和H2FPEF评分进行回顾性诊断,并评估两种评分的诊断一致性。建立了H2FPEF和HFA-PEFF评分诊断HFpEF-AF和HFpEF的接收者操作特征曲线(ROC),并在此基础上评估了两种评分的诊断性能。结果 两组患者的 HFA-PEFF 评分无差异(P=0.070),但 HFpEF-AF 组患者的 H2FPEF 平均评分和评分不低于 6 分的患者比例高于 HFpEF 组(P2FPEF 评分在诊断所有 HFpEF 患者时表现出较高的性能,曲线下面积(AUC)分别为 0.892 和 0.922,而 HFA-PEFF 评分在诊断所有 HFpEF 患者时表现出较高的性能,曲线下面积(AUC)分别为 0.892 和 0.922。HFA-PEFF 评分在诊断 HFpEF 和 HFpEF-AF 方面表现相似,AUC 分别为 0.899 和 0.911。结论 HFA-PEFF 评分适用于 HFpEF 和 HFpEF-AF 的诊断,H2FPEF 评分可能会低估中国患者的 HFpEF,其在中国单纯 HFpEF 患者中的适用性仍有待研究。
{"title":"[Applicability of H<sub>2</sub>FPEF and HFA-PEFF Scores in Chinese Patients Suffering From Heart Failure With Preserved Ejection Fraction and Heart Failure With Preserved Ejection Fraction Complicated With Atrial Fibrillation].","authors":"Xiao-Yan Jia, Li-Xiang Liu, Dong-Wei Wang, Xi-Wen Ma, Yong-Ming Liu","doi":"10.3881/j.issn.1000-503X.15826","DOIUrl":"https://doi.org/10.3881/j.issn.1000-503X.15826","url":null,"abstract":"<p><p>Objective To analyze the diagnostic values of H<sub>2</sub>FPEF and HFA-PEFF scores for heart failure with preserved ejection fraction (HFpEF) and HFpEF complicated with atrial fibrillation (HFpEF-AF) in Chinese patients and explore the related factors. Methods A cross-sectional study was conducted.A total of 835 consecutive HFpEF patients treated in the Department of Geriatric Cardiology,the First Hospital of Lanzhou University from 2009 to 2020 were selected and assigned to a HFpEF-AF group (<i>n</i>=267) and a HFpEF group (<i>n</i>=568) according to the presence of AF or not.HFA-PEFF and H<sub>2</sub>FPEF scores were used for retrospective diagnosis and the diagnostic consistency of the two scores was assessed.One hundred and thirty-six healthy volunteers with age and sex matching the patients during the same period were selected as healthy controls.The receiver operating characteristic (ROC) curves were established for H<sub>2</sub>FPEF and HFA-PEFF scores in diagnosing HFpEF-AF and HFpEF,on the basis of which the diagnostic performance of the two scores was evaluated. Results There was no difference in the HFA-PEFF score between the two groups (<i>P</i>=0.070).However,the HFpEF-AF group had higher mean H<sub>2</sub>FPEF score and higher proportion of patients with the score no less than 6 than the HFpEF group (<i>P</i><0.001).According to the ROC curves,HFA-PEFF and H<sub>2</sub>FPEF scores demonstrated high performance in diagnosing all HFpEF patients,with the area under the curve (AUC) of 0.892 and 0.922 and the optimal cut-offs of 4 and 4,respectively.The HFA-PEFF score showed similar performance in diagnosing HFpEF and HFpEF-AF,with the AUC of 0.899 and 0.911,respectively.The H<sub>2</sub>FPEF score had higher performance in diagnosing HFpEF-AF (AUC of approximately 1.000) and low performance in diagnosing HFpEF (AUC of 0.885). Conclusions The HFA-PEFF score is applicable in the diagnosis of both HFpEF and HFpEF-AF.The H<sub>2</sub>FPEF score may underestimate HFpEF in Chinese patients,and its applicability in the Chinese patients with HFpEF alone remains to be investigated.</p>","PeriodicalId":6919,"journal":{"name":"中国医学科学院学报","volume":"46 2","pages":"154-160"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140847354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Family Decision-Making Path for the Referral of Terminal Patients in Tertiary Hospitals]. [三级医院临终病人转诊的家庭决策路径]。
Q4 Medicine Pub Date : 2024-04-01 DOI: 10.3881/j.issn.1000-503X.15964
Shan Zhang, Xiao-Tian Zhang, Peng Yue, Jing Yang, Zhuo Yin

Objective To gain an in-depth understanding of the motivations,patterns,and related factors in family decision-making regarding the referral of terminal patients in tertiary hospitals. Methods Using purposive sampling,terminal patients and their family members from three tertiary hospitals in Beijing were selected as subjects.Semi-structured interviews were conducted,and the interview data were subjected to thematic analysis. Results Following the saturation principle,a total of 11 patients and 15 family members were included.The interview data were organized and analyzed,yielding six major themes:decision premises,decision patterns,family support,support from the referring hospital's medical team,referral channel conditions,and involvement of volunteer teams and social support.Based on these findings,a flowchart illustrating the family decision-making process for the referral of terminal patients was constructed. Conclusions The study provides a comprehensive analysis of various factors influencing family decision-making in the referral of terminal patients in tertiary hospitals.The results underscore the significance of internal and external factors,emphasizing the integrated impact of decision patterns,family support,medical team support,referral channel conditions,and the involvement of volunteer teams and social support.The research offers profound insights into improving the referral process for terminal patients and enhancing the quality of family decision-making.It provides valuable recommendations for future improvements in medical services and decision support.

目的 深入了解三级医院临终患者家属转诊决策的动机、模式及相关因素。方法 采用目的取样法,选取北京三家三级医院的临终患者及其家属作为研究对象,进行半结构式访谈,并对访谈资料进行主题分析。对访谈资料进行整理和分析,得出六大主题:决策前提、决策模式、家庭支持、转诊医院医疗团队支持、转诊渠道条件、志愿者团队参与和社会支持。在此基础上,构建了临终患者转诊家庭决策流程图。结论 该研究全面分析了三级医院临终患者转诊过程中影响家属决策的各种因素,结果强调了内外部因素的重要性,强调了决策模式、家属支持、医疗团队支持、转诊渠道条件、志愿者团队参与和社会支持的综合影响,为改善临终患者转诊流程、提高家属决策质量提供了深刻的启示,为今后改善医疗服务和决策支持提供了宝贵的建议。
{"title":"[Family Decision-Making Path for the Referral of Terminal Patients in Tertiary Hospitals].","authors":"Shan Zhang, Xiao-Tian Zhang, Peng Yue, Jing Yang, Zhuo Yin","doi":"10.3881/j.issn.1000-503X.15964","DOIUrl":"https://doi.org/10.3881/j.issn.1000-503X.15964","url":null,"abstract":"<p><p>Objective To gain an in-depth understanding of the motivations,patterns,and related factors in family decision-making regarding the referral of terminal patients in tertiary hospitals. Methods Using purposive sampling,terminal patients and their family members from three tertiary hospitals in Beijing were selected as subjects.Semi-structured interviews were conducted,and the interview data were subjected to thematic analysis. Results Following the saturation principle,a total of 11 patients and 15 family members were included.The interview data were organized and analyzed,yielding six major themes:decision premises,decision patterns,family support,support from the referring hospital's medical team,referral channel conditions,and involvement of volunteer teams and social support.Based on these findings,a flowchart illustrating the family decision-making process for the referral of terminal patients was constructed. Conclusions The study provides a comprehensive analysis of various factors influencing family decision-making in the referral of terminal patients in tertiary hospitals.The results underscore the significance of internal and external factors,emphasizing the integrated impact of decision patterns,family support,medical team support,referral channel conditions,and the involvement of volunteer teams and social support.The research offers profound insights into improving the referral process for terminal patients and enhancing the quality of family decision-making.It provides valuable recommendations for future improvements in medical services and decision support.</p>","PeriodicalId":6919,"journal":{"name":"中国医学科学院学报","volume":"46 2","pages":"217-224"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140846975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical and Mechanism Research Progress in Amelioration of Mild Cognitive Impairment via Meditation]. [通过冥想改善轻度认知障碍的临床和机制研究进展]。
Q4 Medicine Pub Date : 2024-04-01 DOI: 10.3881/j.issn.1000-503X.15602
Xiao-Yan Shen, Zheng-Ping Pu

Mild cognitive impairment(MCI)has a high risk of progressing to dementia,with no recommended therapies.Recent studies have shown that meditation has huge potential to improve the cognitive function,with low cost and high safety,being suitable to be applied in the treatment of neurological and psychotic disorders.This paper reviews the application and prospects of meditation in treating MCI from the concept,clinical efficacy,and mechanism of meditation,aiming to provide reference for future clinical studies.

最近的研究表明,冥想在改善认知功能方面潜力巨大,且成本低、安全性高,适合应用于神经和精神疾病的治疗。本文从冥想的概念、临床疗效、机制等方面综述了冥想在治疗 MCI 中的应用和前景,旨在为今后的临床研究提供参考。
{"title":"[Clinical and Mechanism Research Progress in Amelioration of Mild Cognitive Impairment via Meditation].","authors":"Xiao-Yan Shen, Zheng-Ping Pu","doi":"10.3881/j.issn.1000-503X.15602","DOIUrl":"10.3881/j.issn.1000-503X.15602","url":null,"abstract":"<p><p>Mild cognitive impairment(MCI)has a high risk of progressing to dementia,with no recommended therapies.Recent studies have shown that meditation has huge potential to improve the cognitive function,with low cost and high safety,being suitable to be applied in the treatment of neurological and psychotic disorders.This paper reviews the application and prospects of meditation in treating MCI from the concept,clinical efficacy,and mechanism of meditation,aiming to provide reference for future clinical studies.</p>","PeriodicalId":6919,"journal":{"name":"中国医学科学院学报","volume":"46 2","pages":"260-266"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140850264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research Progress in the Association Between Sarcopenic Obesity and Cancer]. [肥胖症与癌症关系的研究进展]。
Q4 Medicine Pub Date : 2024-04-01 DOI: 10.3881/j.issn.1000-503X.15622
Chun-Liu Xu, Yue-Wen Liu, Qi Guo, Ying Yu

As the global prevalence of obesity and the elderly population continues to increase,the incidence of sarcopenic obesity is also on the rise and becoming a global public health concern.Sarcopenic obesity not only increases the incidence of cancer,but is also associated with poor clinical outcomes in various cancers,such as surgical complications,increased risk of death,and possibly even an impact on chemotherapy as well.Therefore,sarcopenic obesity is emerging as an important indicator of prognosis in cancer patients.However,there are limited relevant studies on the association between sarcopenic obesity and cancer in China.This article reviews the definition and diagnosis of sarcopenic obesity,the clinical correlation between sarcopenic obesity and cancer,and the potential mechanisms,with a view to providing a reference for future clinical practice in China.

随着全球肥胖率和老年人口的不断增加,肌肉松弛性肥胖的发病率也在不断上升,已成为一个全球性的公共卫生问题。肌肉松弛性肥胖不仅会增加癌症的发病率,而且与各种癌症的不良临床预后相关,如手术并发症、死亡风险增加,甚至可能对化疗产生影响。本文综述了肌肉疏松性肥胖的定义和诊断、肌肉疏松性肥胖与癌症的临床相关性及潜在机制,以期为我国今后的临床实践提供参考。
{"title":"[Research Progress in the Association Between Sarcopenic Obesity and Cancer].","authors":"Chun-Liu Xu, Yue-Wen Liu, Qi Guo, Ying Yu","doi":"10.3881/j.issn.1000-503X.15622","DOIUrl":"10.3881/j.issn.1000-503X.15622","url":null,"abstract":"<p><p>As the global prevalence of obesity and the elderly population continues to increase,the incidence of sarcopenic obesity is also on the rise and becoming a global public health concern.Sarcopenic obesity not only increases the incidence of cancer,but is also associated with poor clinical outcomes in various cancers,such as surgical complications,increased risk of death,and possibly even an impact on chemotherapy as well.Therefore,sarcopenic obesity is emerging as an important indicator of prognosis in cancer patients.However,there are limited relevant studies on the association between sarcopenic obesity and cancer in China.This article reviews the definition and diagnosis of sarcopenic obesity,the clinical correlation between sarcopenic obesity and cancer,and the potential mechanisms,with a view to providing a reference for future clinical practice in China.</p>","PeriodicalId":6919,"journal":{"name":"中国医学科学院学报","volume":"46 2","pages":"267-274"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140846874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research Progress in the Roles of MRE11-RAD50-NBS1 Complex and Human Diseases]. [MRE11-RAD50-NBS1 复合物的作用与人类疾病的研究进展]。
Q4 Medicine Pub Date : 2024-04-01 DOI: 10.3881/j.issn.1000-503X.15556
Xiao-Hui Xu, Yi-Dan Liu

DNA is susceptible to various factors in vitro and in vivo and experience different forms of damage,among which double-strand break(DSB)is a deleterious form.To maintain the stability of genetic information,organisms have developed multiple mechanisms to repair DNA damage.Among these mechanisms,homologous recombination(HR)is praised for the high accuracy.The MRE11-RAD50-NBS1(MRN)complex plays an important role in HR and is conserved across different species.The knowledge on the MRN complex mainly came from the previous studies in Saccharomyces cerevisiae and Caenorhabditis elegans,while studies in the last decades have revealed the role of mammalian MRN complex in DNA repair of higher animals.In this review,we first introduces the MRN complex regarding the composition,structure,and roles in HR.In addition,we discuss the human diseases such as ataxia-telangiectasia-like disorder,Nijmegen breakage syndrome,and Nijmegen breakage syndrome-like disorder that are caused by dysfunctions in the MRN complex.Furthermore,we summarize the mouse models established to study the clinical phenotypes of the above diseases.

DNA在体外和体内易受各种因素的影响而发生不同形式的损伤,其中双链断裂(DSB)是一种有害的损伤形式。为了维持遗传信息的稳定性,生物体发展出了多种修复DNA损伤的机制,其中同源重组(HR)因其高准确性而备受赞誉。MRE11-RAD50-NBS1(MRN)复合物在HR中发挥着重要作用,并在不同物种间具有保守性。关于MRN复合物的知识主要来自于之前在酿酒酵母和高杆线虫中的研究,而最近几十年的研究则揭示了哺乳动物MRN复合物在高等动物DNA修复中的作用。本综述首先介绍了MRN复合体的组成、结构和在HR中的作用,然后讨论了由MRN复合体功能障碍引起的人类疾病,如共济失调-特朗根扩张症样疾病、奈梅亨断裂综合征和奈梅亨断裂综合征样疾病,并总结了为研究上述疾病的临床表型而建立的小鼠模型。
{"title":"[Research Progress in the Roles of MRE11-RAD50-NBS1 Complex and Human Diseases].","authors":"Xiao-Hui Xu, Yi-Dan Liu","doi":"10.3881/j.issn.1000-503X.15556","DOIUrl":"10.3881/j.issn.1000-503X.15556","url":null,"abstract":"<p><p>DNA is susceptible to various factors <i>in vitro</i> and <i>in vivo</i> and experience different forms of damage,among which double-strand break(DSB)is a deleterious form.To maintain the stability of genetic information,organisms have developed multiple mechanisms to repair DNA damage.Among these mechanisms,homologous recombination(HR)is praised for the high accuracy.The MRE11-RAD50-NBS1(MRN)complex plays an important role in HR and is conserved across different species.The knowledge on the MRN complex mainly came from the previous studies in <i>Saccharomyces cerevisiae</i> and <i>Caenorhabditis elegans</i>,while studies in the last decades have revealed the role of mammalian MRN complex in DNA repair of higher animals.In this review,we first introduces the MRN complex regarding the composition,structure,and roles in HR.In addition,we discuss the human diseases such as ataxia-telangiectasia-like disorder,Nijmegen breakage syndrome,and Nijmegen breakage syndrome-like disorder that are caused by dysfunctions in the MRN complex.Furthermore,we summarize the mouse models established to study the clinical phenotypes of the above diseases.</p>","PeriodicalId":6919,"journal":{"name":"中国医学科学院学报","volume":"46 2","pages":"232-241"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140848231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Applications of Artificial Intelligence in Pancreatic Cystic Lesion Imaging]. [人工智能在胰腺囊性病变成像中的应用]。
Q4 Medicine Pub Date : 2024-04-01 DOI: 10.3881/j.issn.1000-503X.15633
Wen-Yi Deng, Fei-Yang Xie, Hua-Dan Xue

As the detection rate of pancreatic cystic lesions(PCL)increases,artificial intelligence(AI)has made breakthroughs in the imaging workflow of PCL,including image post-processing,lesion detection,segmentation,diagnosis and differential diagnosis.AI-based image post-processing can optimize the quality of medical images and AI-assisted models for lesion detection,segmentation,diagnosis and differential diagnosis significantly enhance the work efficiency of radiologists.This article reviews the application progress of AI in PCL imaging and provides prospects for future research directions.

随着胰腺囊性病变(PCL)检出率的提高,人工智能(AI)在PCL影像学工作流程中取得了突破性进展,包括图像后处理、病灶检测、分割、诊断和鉴别诊断等。基于人工智能的图像后处理可以优化医学影像质量,人工智能辅助的病灶检测、分割、诊断和鉴别诊断模型显著提高了放射科医生的工作效率。本文回顾了人工智能在PCL影像学中的应用进展,并对未来的研究方向进行了展望。
{"title":"[Applications of Artificial Intelligence in Pancreatic Cystic Lesion Imaging].","authors":"Wen-Yi Deng, Fei-Yang Xie, Hua-Dan Xue","doi":"10.3881/j.issn.1000-503X.15633","DOIUrl":"10.3881/j.issn.1000-503X.15633","url":null,"abstract":"<p><p>As the detection rate of pancreatic cystic lesions(PCL)increases,artificial intelligence(AI)has made breakthroughs in the imaging workflow of PCL,including image post-processing,lesion detection,segmentation,diagnosis and differential diagnosis.AI-based image post-processing can optimize the quality of medical images and AI-assisted models for lesion detection,segmentation,diagnosis and differential diagnosis significantly enhance the work efficiency of radiologists.This article reviews the application progress of AI in PCL imaging and provides prospects for future research directions.</p>","PeriodicalId":6919,"journal":{"name":"中国医学科学院学报","volume":"46 2","pages":"275-280"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140849724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Detection and Significance of Molecular Markers in Immunotherapy and Targeted Therapy of Colorectal Cancer in Tibet]. [西藏大肠癌免疫治疗和靶向治疗中分子标记物的检测及其意义]。
Q4 Medicine Pub Date : 2024-04-01 DOI: 10.3881/j.issn.1000-503X.15852
Han-Huan Luo, Bin-Yun Liu, Zhen Huo, BIANbazhaxi, Qian Wang, DUObula, NImazhuoma, Zhen DA, Han Wang, Ping-Ping Guo

Objective To study the expression of SWI/SNF-related,matrix-associated,actin-dependent regulator of chromatin,subfamily A,member 4(SMARCA4)/Brahma-related gene 1,V-raf murine sarcoma viral oncogene homolog B(BRAF),P53,programmed cell death protein-1(PD-1),and programmed death-ligand 1(PD-L1),and changes in the expression of BRAF and neurotrophic tyrosine receptor kinase(NTRK) in the patients with colorectal cancer in Tibet,thereby providing a basis for targeted therapy and immunotherapy for this disease in Tibet. Methods A total of 64 patients with colorectal cancer resected in the Tibet Autonomous Region People's Hospital from January 2015 to July 2021 were enrolled in this study.The expression of SMARCA4,BRAF,P53,PD-1,and PD-L1 was detected by immunohistochemical staining.The gene fusion involving NTRK1,NTRK2,and NTRK3 was detected by fluorescence in situ hybridization,and the BRAF V600E gene mutation by polymerase chain reaction. Results The 64 patients with colorectal cancer were at a male-to-female ratio of 1.21∶1,with the mean age of (56.59±13.27) years.The tumors were located in the colon in 46(71.88%) patients and in the rectum in 18(28.12%) patients.Sixty(93.75%) patients presented adenocarcinoma,and 4(6.25%) patients presented other types of tumors.The patients in T1/T2 and T3/T4 phases accounted for 17.19%(n=11) and 82.81%(n=53),respectively.Lymph node metastasis occurred in 24(37.50%) patients.The immunohistochemical staining results showed partially down-regulated or absent expression of SMARCA4 in 1(1.56%) patient,positive BRAF expression in 4(6.25%) patients,and mutant expression of P53 in 35(54.69%) patients.The PD-1-expressing tumor associated immune cell was proportion score<10% in 45(70.31%) patients and≥10% in 19(29.69%) patients.The PD-L1 combined positive score was<10 in 52(81.25%) patients and≥10 in 12(18.75%) patients.The gene fusion of NTRK1,NTRK2,and NTRK3 was negative in all the patients,and BRAF V600E gene mutation was positive in 4(6.25%) patients.The SMARCA4 gene alteration was not detected in the patient with partial expression missing of SMARCA4.The PD-L1 combine positive score was correlated with the deficient mismatch repair(dMMR)/microsatellite instability-high (MSI-H) and the PD-1 expression (χ2=10.223,P=0.001;χ2=11.979,P=0.001). Conclusions The down-regulated or absent SMARCA4 expression and NTRK gene fusion are rare in the patients with colorectal cancer in Tibet.A few patients present BRAF V600E gene mutations,and Pan-TRK and BRAF expression can be used for the primary screening of NTRK gene fusion and BRAF gene mutation.The patients with dMMR/MSI-H are prone to high expression of PD-L1 and expected to benefit from immunotherapy.No significant correlation exists between P53 mutation and PD-L1 expression.The high expression of PD-1 is positively correlated with the high expression of PD-L1.

目的 研究SWI/SNF相关、基质相关、肌动蛋白依赖性染色质调节因子A亚家族成员4(SMARCA4)/Brahma相关基因1、V-raf小鼠肉瘤病毒癌基因同源物B(BRAF)、P53、程序性细胞死亡蛋白-1(PD-1)和程序性死亡配体1(PD-L1)在结直肠癌患者中的表达,以及BRAF和神经营养性酪氨酸受体激酶(NTRK)的表达变化、和程序性死亡配体1(PD-L1),以及BRAF和神经营养酪氨酸受体激酶(NTRK)的表达变化,从而为西藏结直肠癌的靶向治疗和免疫治疗提供依据。方法 以2015年1月至2021年7月在西藏自治区人民医院切除的64例结直肠癌患者为研究对象,通过免疫组化染色检测SMARCA4、BRAF、P53、PD-1和PD-L1的表达,荧光原位杂交检测NTRK1、NTRK2和NTRK3的基因融合,聚合酶链反应检测BRAF V600E基因突变。结果 64例结直肠癌患者男女比例为1.21∶1,平均年龄为(56.59±13.27)岁,肿瘤位于结肠的占46例(71.88%),位于直肠的占18例(28.12%)。肿瘤位于T1/T2期和T3/T4期的患者分别占17.19%(n=11)和82.免疫组化染色结果显示,1例患者(1.PD-1表达的肿瘤相关免疫细胞比例评分χ2=10.223,P=0.001;χ2=11.979,P=0.001)。结论 SMARCA4表达下调或缺失、NTRK基因融合在西藏结直肠癌患者中罕见,少数患者存在BRAF V600E基因突变,Pan-TRK和BRAF表达可用于NTRK基因融合和BRAF基因突变的初筛。P53基因突变与PD-L1表达无明显相关性,PD-1高表达与PD-L1高表达呈正相关。
{"title":"[Detection and Significance of Molecular Markers in Immunotherapy and Targeted Therapy of Colorectal Cancer in Tibet].","authors":"Han-Huan Luo, Bin-Yun Liu, Zhen Huo, BIANbazhaxi, Qian Wang, DUObula, NImazhuoma, Zhen DA, Han Wang, Ping-Ping Guo","doi":"10.3881/j.issn.1000-503X.15852","DOIUrl":"https://doi.org/10.3881/j.issn.1000-503X.15852","url":null,"abstract":"<p><p>Objective To study the expression of SWI/SNF-related,matrix-associated,actin-dependent regulator of chromatin,subfamily A,member 4(SMARCA4)/Brahma-related gene 1,V-raf murine sarcoma viral oncogene homolog B(BRAF),P53,programmed cell death protein-1(PD-1),and programmed death-ligand 1(PD-L1),and changes in the expression of BRAF and neurotrophic tyrosine receptor kinase(NTRK) in the patients with colorectal cancer in Tibet,thereby providing a basis for targeted therapy and immunotherapy for this disease in Tibet. Methods A total of 64 patients with colorectal cancer resected in the Tibet Autonomous Region People's Hospital from January 2015 to July 2021 were enrolled in this study.The expression of SMARCA4,BRAF,P53,PD-1,and PD-L1 was detected by immunohistochemical staining.The gene fusion involving NTRK1,NTRK2,and NTRK3 was detected by fluorescence <i>in situ</i> hybridization,and the BRAF V600E gene mutation by polymerase chain reaction. Results The 64 patients with colorectal cancer were at a male-to-female ratio of 1.21∶1,with the mean age of (56.59±13.27) years.The tumors were located in the colon in 46(71.88%) patients and in the rectum in 18(28.12%) patients.Sixty(93.75%) patients presented adenocarcinoma,and 4(6.25%) patients presented other types of tumors.The patients in T1/T2 and T3/T4 phases accounted for 17.19%(<i>n</i>=11) and 82.81%(<i>n</i>=53),respectively.Lymph node metastasis occurred in 24(37.50%) patients.The immunohistochemical staining results showed partially down-regulated or absent expression of SMARCA4 in 1(1.56%) patient,positive BRAF expression in 4(6.25%) patients,and mutant expression of P53 in 35(54.69%) patients.The PD-1-expressing tumor associated immune cell was proportion score<10% in 45(70.31%) patients and≥10% in 19(29.69%) patients.The PD-L1 combined positive score was<10 in 52(81.25%) patients and≥10 in 12(18.75%) patients.The gene fusion of NTRK1,NTRK2,and NTRK3 was negative in all the patients,and BRAF V600E gene mutation was positive in 4(6.25%) patients.The SMARCA4 gene alteration was not detected in the patient with partial expression missing of SMARCA4.The PD-L1 combine positive score was correlated with the deficient mismatch repair(dMMR)/microsatellite instability-high (MSI-H) and the PD-1 expression (<i>χ<sup>2</sup></i>=10.223,<i>P</i>=0.001;<i>χ<sup>2</sup></i>=11.979,<i>P</i>=0.001). Conclusions The down-regulated or absent SMARCA4 expression and NTRK gene fusion are rare in the patients with colorectal cancer in Tibet.A few patients present BRAF V600E gene mutations,and Pan-TRK and BRAF expression can be used for the primary screening of NTRK gene fusion and BRAF gene mutation.The patients with dMMR/MSI-H are prone to high expression of PD-L1 and expected to benefit from immunotherapy.No significant correlation exists between P53 mutation and PD-L1 expression.The high expression of PD-1 is positively correlated with the high expression of PD-L1.</p>","PeriodicalId":6919,"journal":{"name":"中国医学科学院学报","volume":"46 2","pages":"184-192"},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140851938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中国医学科学院学报
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1